News
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.
Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results